Grifols S.A.
Develops and produces plasma-derived medicines and biopharmaceutical solutions.
GRF | MC
Overview
Corporate Details
- ISIN(s):
- ES0171996087 (+4 more)
- LEI:
- 959800HSSNXWRKBK4N60
- Country:
- Spain
- Address:
- Avenida de la Generalitat 152-158, 08174 Sant Cugat del Vallès
- Website:
- https://www.grifols.com/en/home
- Sector:
- Manufacturing
Description
Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-02-06 11:33 |
Cambio de categoría de consejero.
|
Spanish | 39.4 KB | ||
| 2024-02-05 17:47 |
Grifols anuncia cambios en su estructura de gobierno corporativo.
|
Spanish | 47.1 KB | ||
| 2024-01-26 18:55 |
Como continuación de la comunicación presentada el 10 de enero.
|
Spanish | 41.3 KB | ||
| 2024-01-14 20:01 |
Como continuación de las comunicaciones presentadas la semana pasada por la Soc…
|
Spanish | 40.9 KB | ||
| 2024-01-10 15:15 |
Grifols invita a inversores a la conferencia telefónica el 11 de enero
|
Spanish | 42.9 KB | ||
| 2024-01-09 19:11 |
Traducción al inglés del OIR enviado esta tarde In connection with recent false…
|
English | 161.7 KB | ||
| 2024-01-02 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2023-12-29 12:26 |
Grifols ha alcanzado una Alianza Estratégica y Contrato de Compraventa de Accio…
|
Spanish | 39.2 KB | ||
| 2023-12-19 08:34 |
El Consejo de Administración aprueba modificar el Reglamento del Consejo. Cambi…
|
Spanish | 61.8 KB | ||
| 2023-11-02 08:11 |
Grifols anuncia la información financiera del tercer trimestre de 2023
|
Spanish | 1.6 MB | ||
| 2023-10-20 08:36 |
El Consejo de Administración de Grifols ha aprobado una política de "clawback" …
|
Spanish | 90.9 KB | ||
| 2023-09-18 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2023-07-27 08:13 |
Grifols anuncia la información financiera del segundo trimestre de 2023
|
Spanish | 1.1 MB | ||
| 2023-06-19 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2023-06-16 13:29 |
Junta General Ordinaria 2023.
|
Spanish | 176.1 KB |
Automate Your Workflow. Get a real-time feed of all Grifols S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Grifols S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Grifols S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
